Vivus Inc. (NASDAQ:VVUS) is having an absolutely awful day, with the stock down more than 13% after the company reported its Q4 results. The launch of its first-in-class obesity drug Qsymia was very highly anticipated among investors with the market potential being huge in this space, but sales just aren’t panning out that way. VIVUS, Inc. (NASDAQ:VVUS) stock opened at $5.77 in last session, and closed at $5.86, while the day range of VIVUS, Inc. (NASDAQ:VVUS) stock is $5.77 – $6.24. The stock showed a positive weekly performance of -18.61%.
The $34 million micro-mini capped bio tech firm Ventrus Biosciences Inc. (NASDAQ:VTUS) reported updates from its ongoing trial of target drug VEN 307 on 13th were designed to determine the efficacy and the safety aspects of its target drug “Diltiazem Hydrochloride” which is applied in the form of a cream to bring down pain in patients suffering from skin. Ventrus Biosciences Inc. (NASDAQ:VTUS) stock opened at $1.53 in last session, and closed at $1.46 by losing -4.57%. The 52 week range of $1.45 – 4.69. Company’s market capitalization is $29.05M.
Constrained hospital and emergency services budgets continue to hamper sales at Allied Healthcare Products Inc., (NASDAQ:AHPI) which reported a second-quarter net sales decline of $1.2 million to $8.7 million compared with the prior-year period. Allied Healthcare Products Inc. (NASDAQ:AHPI) stock decreased -0.90% and finished the last session at $2.20. The EPS of the stock remained -0.23. Company’s market capitalization is $17.66M.
Pharmaceuticals group GlaxoSmithKline plc (ADR) (NYSE:GSK) is another global giant currently offering a dividend yield well above the market average. GSK reported core earnings-per-share (EPS) growth of 4% on turnover growth of 1% when announcing its annual results earlier this month. The board guided for accelerating growth in 2014, saying it expects turnover to rise by 2% and EPS by 4%-8%. GlaxoSmithKline plc (ADR) (NYSE:GSK) stock opened the session at $55.52, and closed the session at $55.70. The 52 week range of the GlaxoSmithKline plc (ADR) (NYSE:GSK) stock remained $43.68 – 56.73 and the day range was $55.46 – 56.12.
Leave a Reply